Commentary · 30 Sep 2024
Conference abstractPublished 26 Oct 2015
Evolving biosimilars regulatory landscape: US and EU
Quintiles Inc., USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The regulatory landscape for the development of biosimilars in the US and EU is dynamic as many of the guidelines issued by European Medicines Agency (EMA) have undergone revisions and in 2015, the FDA issued number of revised guidelines for Quality and Scientific Considerations as well as updated Questions and Answers documents that lend much clarity as to FDA expectations. The thinking of the regulators both in the EU and US has evolved over the years and there is a great deal of convergence. This session is designed to provide current status of biosimilar guidelines in the US and EU. The focus will be to identify major updates in order to help sponsors navigate through the complex requirements for the regulatory approval of biosimilars in the US and EU.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 3 Jan 2024
The Evolving Landscape of Pharmaceutical Regulatory Affairs
Conference abstract · 12 Sep 2011
Biomarkers: Evolving regulatory landscape for drug development and diagnostics
Article · 30 Oct 2025
The Evolving Role of Biosimilars in Enhancing Global Healthcare Access
Conference abstract · 2019
Strategic trends, current and future competitive landscape in biologics and biosimilars
More from this journal
The newest in Journal of Bioanalysis & Biomedicine.
Article · 29 Dec 2025
Label-Free Biosensing: Revolutionizing Disease Detection and Drug Discovery
Article · 29 Dec 2025
Epigenetic Modifications: Bioanalysis for Disease and Therapeutics
Article · 29 Dec 2025
Advancing Bioanalysis: New Tech, AI, and Precision Medicine
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioanalysis & Biomedicine
- BylineArticles whose byline prints “Kamali Chance”

